In contrast, IgG and IgA cross-reactivity was higher in the COVID-19 vaccinated cohort than in the dengue-recovered cohort, suggesting that natural dengue infection induces antibodies targeting non-cross-reactive epitopes (Figure 3D). The gene discussed is CD79A; the disease is dengue disease.